CadiAQ Valve Technologies presents at TCT 2010
CardiAQ Valve Technologies (“CVT”) to present latest in vivo results of its TranscatheterMitral Valve Implantation...
Search for Articles
Sep 20, 2010
Jun 23, 2010
miRagen Therapeutics, Inc. forms alliance with Santaris Pharma
Santaris Pharma A/S and miRagen Therapeutics, Inc. Form Strategic Alliance to Develop microRNA-targeted Medicines for...
Jun 1, 2010
CardiAQ Valve Technologies moves to new headquarters in Irvine, CA
CardiAQ Valve Technologies (“CVT”) completes move of its headquarters to a specialized facility in Irvine,...
May 20, 2010
CardiAQ Valve Technologies presents at EuroPCR 2010
CardiAQ Valve Technologies (“CVT”) to disclose data during “EuroPCR 2010” about the world’s first successful...
Jan 12, 2010
CardiAQ Valve Technologies closes $6.5M Series A
Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming...
Jun 9, 2009
miRagen Therapeutics, Inc. extends Series A to $12M
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA...